Trifluoromethyldeschloroketamine

Trifluoromethyldeschloroketamine

Trifluoromethyldeschloroketamine (also known as TFMK or 3F-K) is a dissociative psychedelic drug that is a structural analog of ketamine. It is part of the arylcyclohexylamine class of compounds and is known for its potent psychoactive effects.

Chemistry

Trifluoromethyldeschloroketamine is a member of the arylcyclohexylamine class, which also includes other dissociative substances like phencyclidine (PCP), methoxetamine (MXE), and dextromethorphan (DXM). The chemical structure of TFMK is similar to that of ketamine, with the key difference being the replacement of the chlorine atom with a trifluoromethyl group.

Pharmacology

The exact pharmacology of trifluoromethyldeschloroketamine is not fully understood. However, it is believed to act primarily as an NMDA receptor antagonist. This means it blocks the action of the NMDA receptor, a type of glutamate receptor that is involved in learning, memory, and perception. By blocking this receptor, TFMK can produce a range of psychoactive effects, including dissociation, hallucinations, and changes in perception.

Effects

The effects of trifluoromethyldeschloroketamine can vary widely depending on the dose, the individual's physiology, and the context in which it is used. Common effects reported by users include feelings of detachment or dissociation from the body, intense hallucinations, changes in the perception of time and space, and euphoria. Some users also report experiencing negative effects such as anxiety, confusion, and memory loss.

Legal Status

The legal status of trifluoromethyldeschloroketamine varies by country. In some countries, it is classified as a controlled substance, while in others it is legal to possess and use. It is always recommended to check the local laws before using any psychoactive substance.

See Also

• Ketamine
• Dissociative
• Psychedelic drug
• Arylcyclohexylamine
• NMDA receptor antagonist